To include your compound in the COVID-19 Resource Center, submit it here.

Advair salmeterol/fluticasone: Postmarketing study start

FDA ordered 4 pharmas to conduct postmarketing trials to evaluate the safety of their respective LABA drugs with or without inhaled corticosteroids to treat asthma. The decision follows

Read the full 289 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE